CARLIE FOX: Open Payments
NPI 1609128255 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,531 in 53 payments from 16 companies in 2025. Trend: 2023 $2,733 · 2024 $1,776 · 2025 $1,531
Food & beverage: $1,346Education: $185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $492 |
| Novartis Pharmaceuticals Corporation | 4 | $242 |
| SANOFI-AVENTIS U.S. LLC | 2 | $185 |
| LEO Pharma Inc. | 2 | $134 |
| Galderma Laboratories, L.P. | 3 | $89 |
| Incyte Corporation | 2 | $86 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| UCB, Inc. | 2 | $49 |
| Organon LLC | 4 | $47 |
| GENZYME CORPORATION | 1 | $37 |
Products named: BOTOX, DUPIXENT, ANZUPGO, OPZELURA, SKYRIZI, Rhapsido, NEMLUVIO, Bimzelx.
Industry payments across AZ — which companies pay providers there.
